Literature DB >> 16959858

Development of respiratory control instability in heart failure: a novel approach to dissect the pathophysiological mechanisms.

Charlotte H Manisty1, Keith Willson, Roland Wensel, Zachary I Whinnett, Justin E Davies, William L G Oldfield, Jamil Mayet, Darrel P Francis.   

Abstract

Observational data suggest that periodic breathing is more common in subjects with low F(ETCO(2)), high apnoeic thresholds or high chemoreflex sensitivity. It is, however, difficult to determine the individual effect of each variable because they are intrinsically related. To distinguish the effect of isolated changes in chemoreflex sensitivity, mean F(ETCO(2)) and apnoeic threshold, we employed a modelling approach to break their obligatory in vivo interrelationship. We found that a change in mean CO(2) fraction from 0.035 to 0.045 increased loop gain by 70 +/- 0.083% (P < 0.0001), irrespective of chemoreflex gain or apnoea threshold. A 100% increase in the chemoreflex gain (from 800 l min(-1) (fraction CO(2))(-1)) resulted in an increase in loop gain of 275 +/- 6% (P < 0.0001) across a wide range of values of steady state CO(2) and apnoea thresholds. Increasing the apnoea threshold F(ETCO(2)) from 0.02 to 0.03 had no effect on system stability. Therefore, of the three variables the only two destabilizing factors were high gain and high mean CO(2); the apnoea threshold did not independently influence system stability. Although our results support the idea that high chemoreflex gain destabilizes ventilatory control, there are two additional potentially controversial findings. First, it is high (rather than low) mean CO(2) that favours instability. Second, high apnoea threshold itself does not create instability. Clinically the apnoea threshold appears important only because of its associations with the true determinants of stability: chemoreflex gain and mean CO(2).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959858      PMCID: PMC1804209          DOI: 10.1113/jphysiol.2006.116764

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  50 in total

1.  The causes of periodic or Cheyne-Stokes breathing.

Authors:  C G Douglas; J S Haldane
Journal:  J Physiol       Date:  1909-06-15       Impact factor: 5.182

2.  Delay equation analysis of human respiratory stability.

Authors:  B Vielle; G Chauvet
Journal:  Math Biosci       Date:  1998-09       Impact factor: 2.144

3.  A minimal mathematical model of human periodic breathing.

Authors:  D W Carley; D C Shannon
Journal:  J Appl Physiol (1985)       Date:  1988-09

4.  Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications.

Authors:  D P Francis; K Willson; L C Davies; A J Coats; M Piepoli
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

5.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.

Authors:  P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

6.  Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence.

Authors:  Ugo Corrà; Massimo Pistono; Alessandro Mezzani; Alberto Braghiroli; Andrea Giordano; Paola Lanfranchi; Enzo Bosimini; Marco Gnemmi; Pantaleo Giannuzzi
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

7.  Effect of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure.

Authors:  R D Steens; T W Millar; X Su; D Biberdorf; P Buckle; M Ahmed; M H Kryger
Journal:  Sleep       Date:  1994-02       Impact factor: 5.849

8.  Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation.

Authors:  J B Skatrud; J A Dempsey
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-09

9.  Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure.

Authors:  P J Hanly; N S Zuberi-Khokhar
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

10.  Experimentally induced Cheyne-Stokes breathing.

Authors:  N S Cherniack; C von Euler; I Homma; F F Kao
Journal:  Respir Physiol       Date:  1979-07
View more
  9 in total

1.  Acetazolamide and cerebrovascular function at high altitude.

Authors:  Luc J Teppema; Remco R Berendsen
Journal:  J Physiol       Date:  2012-06-15       Impact factor: 5.182

Review 2.  Physiology in medicine: obstructive sleep apnea pathogenesis and treatment--considerations beyond airway anatomy.

Authors:  Jerome A Dempsey; Ailiang Xie; David S Patz; David Wang
Journal:  J Appl Physiol (1985)       Date:  2013-11-07

Review 3.  Pathophysiology of central sleep apneas.

Authors:  Adam B Hernandez; Susheel P Patil
Journal:  Sleep Breath       Date:  2016-01-19       Impact factor: 2.816

Review 4.  Congestive heart failure and central sleep apnea.

Authors:  Scott A Sands; Robert L Owens
Journal:  Crit Care Clin       Date:  2015-07       Impact factor: 3.598

5.  Quantification of periodic breathing in premature infants.

Authors:  Mary A Mohr; Karen D Fairchild; Manisha Patel; Robert A Sinkin; Matthew T Clark; J Randall Moorman; Douglas E Lake; John Kattwinkel; John B Delos
Journal:  Physiol Meas       Date:  2015-05-27       Impact factor: 2.833

6.  Dynamic CO2 therapy in periodic breathing: a modeling study to determine optimal timing and dosage regimes.

Authors:  Yoseph Mebrate; Keith Willson; Charlotte H Manisty; Resham Baruah; Jamil Mayet; Alun D Hughes; Kim H Parker; Darrel P Francis
Journal:  J Appl Physiol (1985)       Date:  2009-07-23

7.  Effects of stabilizing or increasing respiratory motor outputs on obstructive sleep apnea.

Authors:  Ailiang Xie; Mihaela Teodorescu; David F Pegelow; Mihai C Teodorescu; Yuansheng Gong; Jessica E Fedie; Jerome A Dempsey
Journal:  J Appl Physiol (1985)       Date:  2013-04-18

Review 8.  Clinical consequences of altered chemoreflex control.

Authors:  Maria Plataki; Scott A Sands; Atul Malhotra
Journal:  Respir Physiol Neurobiol       Date:  2013-05-13       Impact factor: 1.931

9.  Prediction of the Chemoreflex Gain by Common Clinical Variables in Heart Failure.

Authors:  Gianluca Mirizzi; Alberto Giannoni; Andrea Ripoli; Giovanni Iudice; Francesca Bramanti; Michele Emdin; Claudio Passino
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.